Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PHM 411 > Unit 2 review > Flashcards

Unit 2 review Flashcards

1
Q

Define the basic economic concept of demand and the relationship outlined in the law of demand.

A

-Limited resources influence consumer demand for health care
-Decrease in price=increase in quantity demanded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

change in quantity demanded

A

Assumes price of good/service changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

change in demand

A

Assumes price of good/service held constant, horizontal shift on graph, represents healthcare system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the factors that lead to a change in demand for a product or service

A

price of good, income of consumers, number of consumers in the market, attitude, tastea, and preferences of consumers, consumer expectations of future prices and income.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define the basic economic concept of elasticity of demand

A

Measures how responsive is the reaction to a price change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

factors that impact the elasticity of demand for a product or service

A

availability of substitutes(more substitutes=more elastic), price relative to income(more expensive=more elastic), necessity v. luxury, short run v. long run

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define the basic economic concept of supply and the relationship outlined in the law of supply.

A

-Similar to demand, but from supplier perspective
-Increase in price=increase in quantity supplied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or false: a change is quantity supplied is caused by demand not a change in supply.

A

False. Caused by change in supply. Independent of demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the factors that lead to a change in supply for a product or service

A

techniques of production, number of sellers in market, resource costs, price of related goods, seller expectations with respect to future prices and income

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

perfect competition

A

Many buyers and sellers – no concentration of power
Freedom of entry and exit – enter/leave at will
Standardized products – many interchangeable substitutes
Full and free information – complete knowledge of prices, quality
No collusion – each organization acts independently
Standard structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

monopolistic competition

A

relies on product differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

monopoly

A

one seller(brand name)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

oligopoly

A

multiple sellers of similiar products(antihistamines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain how the economics of health care is different from the economics of other industries.

A

-Numbers of buyers and sellers
-Entry and exit (licensing, accreditation, etc.)
-Variation in products, services, and quality
-Full and free information
-Inelastic demand
-Universal demand
-Unpredictability of illness
-Health care as a “right”
-Supplier-induced demand
-Third-party insurance and -patient-induced demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe how the economic performance of the healthcare system could be improved.

A

patients aware of costs, provider feedback about performance, reimbursement incentives/penalties, balancing cost and value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

list price

A

estimated average price for a drug, publically disclosed, price before discounts and rebates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

net price

A

actual price paid for drug, closely gaurded secret, price after discounts and rebates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Estimated price

A

payer estimate of net prices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

drug pricing terms used by manufacturers

A

Wholesale acquisition cost(WAC), set the list price

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

the factors that influence manufacturer drug prices, and the rationale for those prices.

A

Production costs
Research and development costs
Taxes and other costs
Profits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

factors influencing how much wholesalers pay for drugs

A

Discounts based on volume, prompt payment, sale of short dated products, performance metrics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

associated pricing terms with wholesalers

A

average manufacturer price(AMP): WAC-X%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

factors influencing how much pharmacies pay for drugs

A

Size of discount tied to market power
Chain v. independent pharmacy
Group purchasing organizations(GPOs)
Combined purchasing power for small pharmacies
Profit tied to buying/selling prices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

associated pricing terms for pharmacies

A

-Average wholesale price(AWP) WAC+20%
-Actual Acquisition cost(AAC) AWP-17%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Describe the factors influencing how much patients pay for drugs without insurance and associated pricing terms.
U&C price=drug ingredient cost(product)+cost of dispensing(service)+net profit
26
Describe the ways in which PBMs interact with other parts of the healthcare system to impact drug prices
-PBMs interact with manufacturers: rebates and formulary placement -Offer reimbursement to pharmacies -Employers / health plans contract with PBMs to manage drug benefits
27
Describe the structure and goals of contracts between pharmacies and PBMs
Stipulate services be provided by pharmacies in exchange for specific reimbursement, Specify roles and responsibilities, Goals: increase patient access, quality, and safety, lower costs, increase prescription volume and profits
28
Describe PBM drug reimbursement
Estimated acquisition cost(EAC): AWP-20%
29
PBM cost containment approaches
prevent overpayment for generic drugs, Federal upper limit(FUL): Medicaid, requires 3+ drugs on market, Maximum allowable cost(MAC): differs for each payer
30
payer cost
Payer cost=product cost+service cost-patient cost sharing
31
Ingredient cost:
best guess by PBM of what it cost pharmacy to acquire drug, may over/underestimate
32
total pharmacy payment
Total payment: product cost+cost of service+ net profit
33
Describe the “lesser of” provision in pharmacy contracts and how it impacts pharmacy reimbursement.
Contracts state PBM will pay the lowest of 3 approaches:EAC+dispensing fee, MAC+dispensing fee, Pharmacy’s usual and customary charge
34
how pharmacies can lower cost of dispensing.
Automation, Fewer pharmacist and more techs, Increase Rx volume, Shorter operating hours
35
Discuss how Wisconsin Medicaid reimburses pharmacies for prescription drugs.
-Requires all pharmacies to provide AAC -Used to determine “National Average Drug Acquisition Cost” or NADAC -Reimburse [NADAC or WAC+0% or MAC]+ dispensing fee
36
Describe factors impacting the size of rebates, and the implications of drug rebates for manufacturers, PBMs, and employers/health plans.
-Ability to move market share -Number of competitors(more competitors=more rebates) -Preferred status on formulary -OBRA ‘90 law-mandated Medicaid rebates
37
Discuss issues associated with PBM profits and compare how spread pricing and transparent business models affect PBM profitability.
-Spread pricing-profits a PBM makes from buying drugs and reselling them -Rebates are major source of profit -Shift towards transparent business models
38
Describe pharmacist roles within drug information
Timely and accurate research and evaluation of literature including: comprehending study designs, statistical analyses, study limitations, applicability, and clinical significance
39
Describe pharmacist roles within formulary managment
Work on a P&T Committee made up of physicians, nurses, practitioners and pharmacists to create a formulary that benefits patients
40
pharmacist role in utilization management
A set of techniques used in the PBM industry to encourage safe, effective, and economical medication use
41
pharmacist role is client managment
-Management and coordination of the clinical relationship with existing clients -Works to improve the quality of care while controlling or decreasing overall health care costs
42
Industry relations and contracting
Responsible for establishing, maintaining, and enhancing effective relationships with pharmaceutical manufacturers and negotiating contracts with respect to rebates and discounts
43
provider services
The development, monitoring, and maintenance of retail, mail and specialty pharmacy networks. This may include broad, limited, preferred, and/or client custom networks
44
Population Health
Design, implement and monitor outcomes of population-based clinical programs
45
Government Programs
Current Medicare topics of interest: medication assisted treatment (MAT), safe use of opioids,medication adherence, and compounding
46
Identify PBM cost control strategies and summarize their goals.
pharmacy payments, generic substitution, rebate, formularies, disease management programs, mail service programs, Drug utilization review(DUR)
47
Identify unique pharmacist roles within a specialty pharmacy.
-Quality and accreditation -Manufacturer involvement -Clinical programs
48
Describe characteristics of a specialty pharmacy product.
No standard definition, cost and complex
49
filling a specialty drug prescription
-Provider orders prescription -Benefits investigation -Prior authorization and appeals -Financial assistance -Pharmacist evaluation -Consult rom pharmacist -Delivery -Pharmacist clinical management
50
Describe access barriers to specialty drugs and ways to address these barriers.
Completion of prior authorization and appeals, Connecting patients with additional resources
51
Limited distribution drug model
-Manufacturer sells meds directly to pharmacy and has more control over terms and prices -Only pharmacies within limited network can even purchase drug -Pharmacies outside of LDD network cannot access the drug
52
Specialty contract distribution model
Medication only available through one wholesaler
53
Tradition distribution model
-Multiple wholesalers -Pharmacies can ‘shop’ around for best price -No restriction on access
54
Socialized medicine:
-Healthcare is financed and provided by the government -Government employs healthcare practitioners and owns healthcare facilities -UK, Cuba
55
National Health Insurance Model
-Single-payer, government-run, universal health insurance program -Care mostly delivered by non-profit private hospitals -Healthcare services financed by the program with the negotiated reimbursement -Canada, South Korea, Taiwan
56
Decentralized National Health Program
-Required to get health insurance provided by non-profit, nongovernmental health insurance funds or private health insurance -No direct financing/delivery of care by government -Ex: Germany, Japan, Switzerland
57
UK Health care system
National Health Service(NHS), financing through taxation, universal access, 10% drugs have a copay, capped at $104 pounds/year, long wait list so some get private insurance, medical tourism
58
Canada Healthcare System
Medicare, hospitals are non-profit are reimbursed with Medicare, long wait lists, 2/3 have private insurance to supplement
59
Germany healthcare
requires everyone to get private health insurance, funded by taxes on income, government helps set prices of services and drugs
60
Compare the health care systems of other countries with the United States.
The US has less government involvement, Bigger role of private sector, more spending, less distribution of resources, and lots of disparities in access to care and health outcomes.
61
Compare drug policies in other countries with the United States.
Drug policy in other countries: Government negotiates prices for drugs on behalf of the country Government decides coverage of drugs (national formulary) Government determines patient cost-sharing (if any) ↑ negotiating power = ↓ prices
62
Describe the differences between laws and regulations.
Legislative (laws): Statutes give guidance, define authority Administrative (rules): Regulations give detail and outline enforcement within delegated authority
63
Describe a medication shortage
a supply issue that affects how the pharmacy prepares or dispenses a drug product or influences patient care when prescribers must use an alternative agent
64
common causes of shortages
Manufacturing issues delays/capacity Raw materials Increased demand Loss of manufacturing Discontinuation
65
proposed ways to address shortages
-Federal: Food and Drug Administration Safety & Innovation Act (FDASIA) requires companies to notify FDA when manufacturing changes could lead to supply disruption -State: Price gouging prevention laws -Professional: Mitigating Drug Product Shortages Policy Position (1905)
66
Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacist can be reimbursed for services provided in medically underserved areas
67
Equitable Community Access to Pharmacy Services Act.
-Expands Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses -Reimbursement authorized for 85% (or 100% during a declared emergency) of the applicable amount
68
Capitation(prospective)
Prepayment:fixed amount regardless of services provided, Incentive to decrease utilization costs and length of hospitalization stay
69
Per diem(prospective)
Paid flat rate per day regardless of actual cost, Incentive to decrease utilization cost similar to capitation, no incentive to control length of stay
70
Diagnosis-related groups(DRGs)(prospective
Paid flat fee for each diagnosis or disease state, Incentive to decrease utilization cost and length of stay, Used by Medicare A and Medicaid for hospital care
71
Value-Based Purchasing (VBP) Program
Created by the Affordable Care Act for Medicare patients, incenticve payment program for hospitals, reward quality care
72
Describe characteristics and give examples of emerging integrated, interdisciplinary care approaches
-Accountable Care organization (ACO) -Patient centered Medical Home (PCMH) -based on incentive based payments
73
Describe the implications of prospective and non-prospective payment systems on the use of prescription drugs and pharmacy services.
prospective-pharmacy is a cost center, balance between lowest cost and patient outcomes non-prospective: pharmacy is a revenue generator
74
Describe how clinical pharmacist services are billed and reimbursed
Most insurance plans will not pay for clinical pharmacist services, WPQC is a group paying pharmacist for MTM and CMR/s services on FFS basis
75
Describe and discuss the need for health care reform in the United States.
cost, access, quality
76
Describe how the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) impacted the healthcare system.
Largest overhaul of Medicare since 1965 Created medicare part D and current Part C plans E-perscribing Health Savings Accounts
77
health savings accounts (HSAs)
-Must be enrolled in a HDHP -Funds roll over and accumulate year to year -Good for young, healthy people
78
flexible spending accounts (FSAs)
-Can be used with any type of insurance -Funds lost at end of year -Need accurate budgeting -Plans may allow 2.5 grace period or carry over up to $640(2024)
79
Describe the implications of high deductible health plans.
Catastrophic coverage Low premiums, high deductibles
80
Describe the major provisions in the Affordable Care Act (ACA)
-Affected almost every aspect of healthcare:Pre-existing conditions, Limits on coverage, Premium increases, 10 essential health benefits, Preventive care at no cost -Modified/repealed: Insurance mandate subsidies/expansion, Health insurance marketplace, Oral contraceptives
81
Describe how the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) impacted the healthcare system.
changed the way medicare reimbures doctors, focus on quality and value
82
Describe the prescription drug provisions in the Inflation Reduction Act of 2022.
impacts medicare part D, federal govn. negoitites price, rebates if price raises faster than inflation, insulin cap, cost sharing vaccines

PHM 411 (28 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions